Vanguard Group
ZBH icon

Vanguard Group’s Zimmer Biomet ZBH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.12B Buy
23,251,295
+198,370
+0.9% +$18.1M 0.03% 450
2025
Q1
$2.61B Buy
23,052,925
+166,763
+0.7% +$18.9M 0.05% 384
2024
Q4
$2.42B Sell
22,886,162
-398,676
-2% -$42.1M 0.04% 411
2024
Q3
$2.51B Sell
23,284,838
-116,440
-0.5% -$12.6M 0.05% 401
2024
Q2
$2.54B Sell
23,401,278
-371,561
-2% -$40.3M 0.05% 368
2024
Q1
$3.14B Sell
23,772,839
-86,486
-0.4% -$11.4M 0.06% 321
2023
Q4
$2.9B Sell
23,859,325
-75,107
-0.3% -$9.14M 0.06% 315
2023
Q3
$2.69B Sell
23,934,432
-198,131
-0.8% -$22.2M 0.07% 309
2023
Q2
$3.51B Sell
24,132,563
-232,201
-1% -$33.8M 0.08% 239
2023
Q1
$3.15B Buy
24,364,764
+309,025
+1% +$39.9M 0.08% 265
2022
Q4
$3.07B Buy
24,055,739
+246,563
+1% +$31.4M 0.08% 261
2022
Q3
$2.49B Buy
23,809,176
+235,871
+1% +$24.7M 0.07% 288
2022
Q2
$2.48B Buy
23,573,305
+470,544
+2% +$49.4M 0.07% 293
2022
Q1
$2.95B Buy
23,102,761
+3,695,510
+19% +$473M 0.07% 292
2021
Q4
$2.47B Buy
19,407,251
+3,254,256
+20% +$413M 0.06% 370
2021
Q3
$2.36B Buy
16,152,995
+99,331
+0.6% +$14.5M 0.06% 354
2021
Q2
$2.58B Buy
16,053,664
+141,663
+0.9% +$22.8M 0.06% 328
2021
Q1
$2.55B Buy
15,912,001
+208,216
+1% +$33.3M 0.07% 311
2020
Q4
$2.42B Sell
15,703,785
-134,524
-0.8% -$20.7M 0.07% 301
2020
Q3
$2.16B Sell
15,838,309
-255,173
-2% -$34.7M 0.07% 288
2020
Q2
$1.92B Sell
16,093,482
-198,780
-1% -$23.7M 0.07% 304
2020
Q1
$1.65B Buy
16,292,262
+335,466
+2% +$33.9M 0.07% 284
2019
Q4
$2.39B Buy
15,956,796
+352,046
+2% +$52.7M 0.08% 256
2019
Q3
$2.14B Buy
15,604,750
+150,789
+1% +$20.7M 0.08% 267
2019
Q2
$1.82B Buy
15,453,961
+145,726
+1% +$17.2M 0.07% 314
2019
Q1
$1.95B Buy
15,308,235
+266,366
+2% +$34M 0.08% 274
2018
Q4
$1.56B Buy
15,041,869
+530,436
+4% +$55M 0.07% 303
2018
Q3
$1.91B Buy
14,511,433
+228,894
+2% +$30.1M 0.07% 269
2018
Q2
$1.59B Buy
14,282,539
+233,100
+2% +$26M 0.07% 330
2018
Q1
$1.53B Buy
14,049,439
+217,442
+2% +$23.7M 0.07% 338
2017
Q4
$1.67B Buy
13,831,997
+192,889
+1% +$23.3M 0.07% 310
2017
Q3
$1.6B Buy
13,639,108
+258,591
+2% +$30.3M 0.07% 294
2017
Q2
$1.72B Buy
13,380,517
+339,106
+3% +$43.5M 0.08% 255
2017
Q1
$1.59B Buy
13,041,411
+464,916
+4% +$56.8M 0.08% 273
2016
Q4
$1.3B Buy
12,576,495
+533,861
+4% +$55.1M 0.07% 305
2016
Q3
$1.57B Buy
12,042,634
+102,052
+0.9% +$13.3M 0.09% 236
2016
Q2
$1.44B Buy
11,940,582
+1,306,447
+12% +$157M 0.09% 243
2016
Q1
$1.13B Buy
10,634,135
+821,326
+8% +$87.6M 0.07% 300
2015
Q4
$1.01B Buy
9,812,809
+232,361
+2% +$23.8M 0.07% 313
2015
Q3
$900M Buy
9,580,448
+236,449
+3% +$22.2M 0.07% 330
2015
Q2
$1.02B Buy
9,343,999
+141,315
+2% +$15.4M 0.07% 313
2015
Q1
$1.08B Buy
9,202,684
+373,899
+4% +$43.9M 0.07% 296
2014
Q4
$1B Buy
8,828,785
+327,556
+4% +$37.2M 0.07% 300
2014
Q3
$855M Buy
8,501,229
+224,072
+3% +$22.5M 0.07% 322
2014
Q2
$860M Buy
8,277,157
+77,811
+0.9% +$8.08M 0.07% 320
2014
Q1
$775M Buy
8,199,346
+161,122
+2% +$15.2M 0.07% 327
2013
Q4
$749M Buy
8,038,224
+182,769
+2% +$17M 0.07% 326
2013
Q3
$645M Sell
7,855,455
-139,410
-2% -$11.5M 0.06% 344
2013
Q2
$599M Buy
+7,994,865
New +$599M 0.06% 349